Practice
Open Access
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
Leora Branfield Day, Husam Abdel-Qadir and Michael Fralick
CMAJ April 26, 2021 193 (17) E612-E615; DOI: https://doi.org/10.1503/cmaj.210300
Leora Branfield Day
Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women’s College Hospital, Toronto, Ont.
MDHusam Abdel-Qadir
Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women’s College Hospital, Toronto, Ont.
MD PhDMichael Fralick
Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women’s College Hospital, Toronto, Ont.
MD PhD SMRelated Articles
- Day, L. B., Abdel-Qadir, H., & Fralick, M. (2021). Bradycardie associée à un traitement au remdésivir contre la COVID-19 chez un homme de 59 ans. CMAJ, 193(25), E987-E991. Accessed May 08, 2024. https://doi.org/10.1503/cmaj.210300-f.
In this issue
Article tools
Respond to this article
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
Leora Branfield Day, Husam Abdel-Qadir, Michael Fralick
CMAJ Apr 2021, 193 (17) E612-E615; DOI: 10.1503/cmaj.210300